ClinConnect ClinConnect Logo
Search / Trial NCT04314570

Saphenous Nerve Block After Tibial Plateau ORIF

Launched by STANFORD UNIVERSITY · Mar 17, 2020

Trial Information

Current as of September 10, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how effective a specific type of pain relief, called a saphenous nerve block, can be after surgery for a tibial plateau fracture. A tibial plateau fracture is a serious injury to the knee area that can cause a lot of pain. Usually, doctors don’t use nerve blocks for this type of surgery because they worry it might hide important pain signals that indicate a serious complication called compartment syndrome. However, researchers believe that the saphenous nerve block might help manage pain without masking those critical warning signs.

To take part in this study, participants must be at least 18 years old and have a tibial plateau fracture that requires surgery. They cannot have certain other serious injuries or conditions that would make it unsafe to receive a nerve block or participate in the study. Those who join can expect to receive the saphenous nerve block during their surgery and will be monitored for its effectiveness in managing pain afterward. This trial is important because it could help improve pain management strategies for patients recovering from this common but painful injury.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Tibial plateau fracture presenting for ORIF
  • Age greater than or equal to 18 years
  • Exclusion Criteria:
  • Other concomitant life-threatening injuries
  • History of chronic pain prior to tibial plateau ORIF
  • Age \<18 years old
  • Pregnancy
  • Any condition impairing patient's ability to consent to participation in study
  • Existing condition contraindicating a nerve block
  • Non-English Speaking

About Stanford University

Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials